ArticleNursing open2026
Health-Related Quality of Life and Associated Factors Among Patients With Bioprosthetic Heart Valve Replacement: A Cross-Sectional Study.
Article in Nursing open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimThe use of bioprosthetic heart valves has significantly increased in recent years due to the aging population and advances in technology. Health-related quality of life (HRQoL) is as important as clinical outcomes. However, little is known about the long-term HRQoL of patients after bioprosthetic heart valve replacement and its relationship with comprehensive treatment adherence and family support. The aim of this study was to assess the HRQoL of patients after bioprosthetic heart valve replacement and further identify its influencing factors.
designA cross-sectional study was performed.
methodsA total of 323 patients who had undergone bioprosthetic heart valve replacement were recruited from a large-scale tertiary hospital in China between March 2021 and March 2022. The EuroQoL Scale (EQ-5D-5L), Treatment Adherence Scale, and Family Support Scale were used to collect the data. Binary logistic regression was used to analyze the data.
resultsThe EQ-5D-5L index score was 0.92, and more than half of the patients (53.6%) reported health-related problems. Binary logistic regression analyses revealed that patients with respiratory disease (OR = 2.46, 95% CI [1.23, 4.89]) and heart failure (OR = 3.79, 95% CI [1.12, 12.83]) were risk factors for HRQoL. Treatment adherence (OR = 0.88, 95% CI [0.83, 0.94]) was a protective factor for HRQoL. Family support was not associated with HRQoL (OR = 1.07, 95% CI [0.97, 1.18]).
conclusionPatients undergoing bioprosthetic heart valve replacement reported various health-related problems. Patients who had respiratory disease or heart failure and had lower treatment adherence reported lower HRQoL. IMPACT: Nurses should pay particular attention to HRQoL assessment, treatment adherence, and comorbidity management in routine care and long-term follow-up after bioprosthetic heart valve replacement. REPORTING
methodThe study followed the STROBE checklist. CONTRIBUTION: No patient or public contribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.